Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $438 | $2 | $2 | $2 |
| Gross Profit | -$438 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| R&D Expenses | $35,698 | $18,328 | $5,958 | $4,124 |
| G&A Expenses | $18,388 | $9,008 | $878 | $818 |
| SG&A Expenses | $18,388 | $9,008 | $878 | $818 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $28 | $0 | $0 |
| Operating Expenses | $54,086 | $27,336 | $6,836 | $4,942 |
| Operating Income | -$54,086 | -$27,336 | -$6,836 | -$4,942 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3,478 | $28 | -$5,161 | -$2,241 |
| Pre-Tax Income | -$50,608 | -$27,308 | -$11,997 | -$7,183 |
| Tax Expense | -$3,528 | $0 | $0 | $0 |
| Net Income | -$47,080 | -$27,308 | -$11,997 | -$7,183 |
| % Margin | – | – | – | – |
| EPS | -1.22 | -0.76 | -0.47 | -0.28 |
| % Growth | -60.5% | -61.7% | -67.9% | – |
| EPS Diluted | -1.22 | -0.76 | -0.47 | -0.28 |
| Weighted Avg Shares Out | 38,490 | 35,871 | 25,367 | 25,367 |
| Weighted Avg Shares Out Dil | 38,490 | 35,871 | 25,367 | 25,367 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $50 | $2 | $2 | $2 |
| EBITDA | -$54,086 | -$27,334 | -$6,834 | -$4,940 |
| % Margin | – | – | – | – |